WuXi Biologics (Cayman) Inc (WXXWY)
3.82
-0.19
(-4.74%)
USD |
OTCM |
Nov 14, 15:58
WuXi Biologics Shareholders Equity (Quarterly): 5.594B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.594B |
| June 30, 2024 | 5.594B |
| December 31, 2023 | 5.690B |
| June 30, 2023 | 5.203B |
| June 30, 2023 | 5.203B |
| December 31, 2022 | 5.080B |
| June 30, 2022 | 5.142B |
| June 30, 2022 | 5.142B |
| December 31, 2021 | 5.064B |
| June 30, 2021 | 5.138B |
| June 30, 2021 | 5.138B |
| December 31, 2020 | 3.148B |
| Date | Value |
|---|---|
| June 30, 2020 | 1.923B |
| June 30, 2020 | 1.923B |
| December 31, 2019 | 1.827B |
| June 30, 2019 | 1.240B |
| June 30, 2019 | 1.240B |
| December 31, 2018 | 1.162B |
| June 30, 2018 | 1.134B |
| June 30, 2018 | 1.134B |
| December 31, 2017 | 616.41M |
| June 30, 2017 | 564.24M |
| June 30, 2017 | 564.24M |
| December 31, 2016 | 38.94M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.827B
Minimum
Dec 2019
5.690B
Maximum
Dec 2023
4.454B
Average
5.138B
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Zai Lab Ltd | 704.18M |
| Sinovac Biotech Ltd | 8.649B |
| CASI Pharmaceuticals Inc | 9.021M |
| Adagene Inc | 56.59M |
| LakeShore Biopharma Co Ltd | 76.35M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.719B |
| Total Liabilities (Quarterly) | 1.577B |
| Debt to Equity Ratio | 0.0531 |
| Current Ratio | 2.911 |
| Net Debt Paydown Yield | 0.59% |